Evaluating Adherence to the Sepsis Bundle and the Effectiveness of Best Practice Alerts by Burnett, Kate M.
University of Kentucky 
UKnowledge 
DNP Projects College of Nursing 
2017 
Evaluating Adherence to the Sepsis Bundle and the Effectiveness 
of Best Practice Alerts 
Kate M. Burnett 
University of Kentucky, kateburnett06@gmail.com 
Follow this and additional works at: https://uknowledge.uky.edu/dnp_etds 
 Part of the Critical Care Commons, Critical Care Nursing Commons, and the Infectious Disease 
Commons 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Recommended Citation 
Burnett, Kate M., "Evaluating Adherence to the Sepsis Bundle and the Effectiveness of Best Practice 
Alerts" (2017). DNP Projects. 168. 
https://uknowledge.uky.edu/dnp_etds/168 
This Practice Inquiry Project is brought to you for free and open access by the College of Nursing at UKnowledge. It 
has been accepted for inclusion in DNP Projects by an authorized administrator of UKnowledge. For more 
information, please contact UKnowledge@lsv.uky.edu. 
STUDENT AGREEMENT: 
I represent that my DNP Project is my original work. Proper attribution has been given to all 
outside sources. I understand that I am solely responsible for obtaining any needed copyright 
permissions. I have obtained and attached hereto needed written permission statements(s) 
from the owner(s) of each third‐party copyrighted matter to be included in my work, allowing 
electronic distribution (if such use is not permitted by the fair use doctrine). 
I hereby grant to The University of Kentucky and its agents a royalty-free, non-exclusive and 
irrevocable license to archive and make accessible my work in whole or in part in all forms of 
media, now or hereafter known. I agree that the document mentioned above may be made 
available immediately for worldwide access unless a preapproved embargo applies. I also 
authorize that the bibliographic information of the document be accessible for harvesting and 
reuse by third-party discovery tools such as search engines and indexing services in order to 
maximize the online discoverability of the document. I retain all other ownership rights to the 
copyright of my work. I also retain the right to use in future works (such as articles or books) all 
or part of my work. I understand that I am free to register the copyright to my work. 
REVIEW, APPROVAL AND ACCEPTANCE 
The document mentioned above has been reviewed and accepted by the student’s advisor, on 
behalf of the advisory committee, and by the Assistant Dean for MSN and DNP Studies, on 
behalf of the program; we verify that this is the final, approved version of the student's DNP 
Project including all changes required by the advisory committee. The undersigned agree to 
abide by the statements above. 
Kate M. Burnett, Student 
Dr. Sheila Melander, Advisor 
Running head: EVALUATING ADHERENCE TO THE SEPSIS BUNDLE  
 
 
 
 
 
DNP Final Project Report 
Evaluating Adherence to the Sepsis Bundle and the Effectiveness of Best Practice Alerts 
 
Kate M. Burnett 
 
 
University of Kentucky 
College of Nursing  
November 30, 2017 
 
 
 
 
 
 
Sheila Melander PhD, APRN, ACNP-BC, FCCM, FAANP, FAAN– Committee Chair 
Brittany Ross, APRN, ANP-C, AG-ACNP-BC – Committee Member/Clinical Mentor 
Michelle Pendleton, DNP, RN, CPHQ- Committee Member 
 
Running head: EVALUATING ADHERENCE TO THE SEPSIS BUNDLE   
 
 
Dedication 
My doctoral work is for my parents, who have always made education a priority and 
supported me in every possible way. Thank you for all of your love and encouragement and for 
always being there for whatever I need. This is for my sister, Mallory, my biggest cheerleader 
and my personal, 24-hour technical support. Thank you for all of the perfectly timed “good luck” 
texts, baked goods waiting for me at home, and for preventing one, maybe two, nervous 
breakdowns. This is for Neil, who could always distract me from homework with sarcastic jokes, 
which were usually at my expense. Thank you for all the little things you have helped me with 
over the past three years. This is for Kim Forsythe, who gave me my first big girl job and who 
was the first person who told me I could be successful in this program. I will never forget your 
encouragement and motivating words. You continue to be an amazing mentor and you will be 
my forever friend.  
   
Running head: EVALUATING ADHERENCE TO THE SEPSIS BUNDLE  
iii 
 
Acknowledgements 
I would like to give a special thanks to my advisor, Dr. Sheila Melander, who has helped 
me through every step of my project. She has constantly encouraged and motivated me 
throughout my educational journey and will continue to be an excellent clinical mentor as I begin 
my new career. I would also like to thank my committee members, Brittany Ross and Michelle 
Pendleton for their expertise during the development of my project. To Amanda Wiggins, thank 
you for your help and patience during the statistical analysis portion of my project. I could not 
have accomplished this section without you. Also, to Whitney Kurtz-Ogilvie, thank you so much 
for your editing and writing style assistance.  
A special thank you to Norton Healthcare and the University of Kentucky for this 
amazing opportunity to advance my education and reach one of my professional goals. I am 
forever grateful for this gift and will give back by working to improve patient care for many 
years to come.  
Norton Healthcare Scholarship Recipient: This Doctor of Nursing Practice project and 
program of study was fully funded through the University of Kentucky College of Nursing and 
Norton Healthcare academic-practice partnership. 
 
 
 
 
Running head: EVALUATING ADHERENCE TO THE SEPSIS BUNDLE  
iv 
 
Table of Contents 
Acknowledgements ........................................................................................................................ iii 
List of Tables .................................................................................................................................. v 
Abstract ........................................................................................................................................... 1 
Background ..................................................................................................................................... 2 
     Centers for Medicare and Medicaid Services Guidelines………………..…………………….3 
     Best Practice Alerts……………………….………………….………………………………...4 
Purpose ............................................................................................................................................ 4 
Methods........................................................................................................................................... 5 
Setting .......................................................................................................................................... 5 
Sample ......................................................................................................................................... 5 
Measures ...................................................................................................................................... 5 
Data Collection ............................................................................................................................ 6 
Data Analysis ............................................................................................................................... 6 
Results ............................................................................................................................................. 7 
Sample Characteristics ................................................................................................................ 7 
Discussion ....................................................................................................................................... 7 
Limitations ................................................................................................................................... 8 
Recommendations for Future Studies.......................................................................................... 9 
Conclusion .................................................................................................................................... 10 
Appendix A ................................................................................................................................... 14 
Appendix B ................................................................................................................................... 15 
References ..................................................................................................................................... 16 
EVALUATING ADHERENCE TO THE SEPSIS BUNDLE 
v 
 
List of Tables 
Table 1. Patient Characteristics of the Study Sample ................................................................... 15 
Table 2. Comparison of Pre and Post BPA Implementation Groups ........................................... 16 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
EVALUATING ADHERENCE TO THE SEPSIS BUNDLE  
1 
 
Abstract 
PURPOSE: To evaluate the adherence to the CMS sepsis recommendations and sepsis bundle 
used by the study health system before and after the implementation of Best Practice Alerts 
(BPAs) and assessing the effect of these alerts on patient outcomes. 
METHODS:   The study was a single-center, process evaluation through a retrospective chart 
review within a southwest healthcare system. The sample consisted of 73 patients for the pre-
implementation period (May 1, 2016-September 7, 2016) and 75 patients for the post-
implementation period (September 8, 2016-April 30, 2017).  
RESULTS: No major differences were found between the two groups with regard to patient age, 
ethnicity, and time of admission. The post-implementation group had a higher incidence of 
timely antibiotic administration (p=.008) with 38% receiving initial antibiotic administration in 
45 minutes or less of meeting sepsis criteria versus 21% in the pre-implementation group. In the 
post-implementation group, 89% of patients met sepsis criteria versus 67% in the pre-
implementation group. The post-implementation group also collected blood cultures in 30 
minutes or less in 61% of patients versus 41% in the pre-implementation group (p=.03). No 
significant difference was found in regard to antibiotic selection, mortality, or length of stay. 
CONCLUSION: The post-implementation group achieved more timely antibiotic administration 
and blood culture collection; however, there was no significant improvement in appropriate 
antibiotic choice, length of stay, or mortality. BPAs were inconsistent with the time that patients 
met sepsis criteria. After years of research and protocol changes, outcomes have not improved, 
indicating a great need for consideration of alternative treatments to improve the care and 
outcomes of sepsis patients.  
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Background 
More than 1.6 million Americans are diagnosed with sepsis annually, which is equal to 
one person every 20 seconds, according to the Sepsis Fact Sheet (2016). In addition, the 
incidence of sepsis is rising 8% each year and is currently the leading cause of death in 
hospitalized patients. Globally, 26 million people are affected by sepsis annually and the disease 
has become the largest killer of children around the world, claiming the lives of more than five 
million children every year (Sepsis Fact Sheet, 2016). It has been estimated that 258,000 
Americans die from sepsis each year; this is one person every two minutes, surpassing deaths 
from prostate cancer, breast cancer, and AIDS combined (Chong, Dumont, Francis-Frank, & 
Balaan, 2015; Sepsis Fact Sheet, 2016).  
Sepsis has been a leading cause of death and a frequent reason for hospital admissions for 
decades, despite multiple attempts at developing protocols and bundles aimed at improving 
outcomes. In 1999, the mortality rate from sepsis was estimated to be between 40 and 60% (Alia 
et al., 1999). Sixteen years later this estimate was still high at 50%, indicating the urgent need to 
improve the care and treatment of sepsis patients (Rusconi et al., 2015).  
Many patients who survive sepsis are left with debilitating physical and mental 
conditions. For example, according to the Sepsis Fact Sheet (2016), thirty-eight amputations are 
performed every day as a result of sepsis. In addition, patients who have been treated for sepsis 
have a shortened life expectancy, are likely to have a decreased quality of life, and are 42% more 
likely to commit suicide. Sepsis is also the cause of more than 75,000 maternal deaths each year 
worldwide and is an increasing cause of death during pregnancy in the United States (Sepsis Fact 
Sheet, 2016).   
According to Cawcutt and Peters (2014), sepsis is responsible for approximately 2% of 
all hospital admissions, with 50% of these patients requiring care in the ICU. Moreover, 10% of 
these patients are considered to have severe sepsis. In patients who are admitted to the ICU due 
to sepsis, the mortality rate is more than 20% and reaches close to 50% in patients with septic 
shock (Rusconi et al., 2015).  
Sepsis also places a financial strain on the healthcare system. In 2009, sepsis was ranked 
as the sixth most common primary diagnosis for patients admitted to the hospital with an 
estimated $15.8 billion in healthcare costs (Chong et al., 2015). The current estimate is greater 
than $24 billion, making this disease the number one cost of hospitalization in our country 
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(Sepsis Fact Sheet, 2016). Each sepsis admission costs approximately $18,400, which is double 
the average cost for other diagnoses. Sixty-two percent of patients treated for sepsis are 
readmitted to the hospital within 30 days of discharge (Sepsis Fact Sheet, 2016). The 
readmission rate for sepsis patients surpasses those of all four medical conditions for which CMS 
currently tracks and penalizes healthcare systems, which include myocardial infarction, heart 
failure, pneumonia, and chronic obstructive pulmonary disease (COPD). In 2013, analysis of 
data obtained from the Nationwide Readmission Database, which consists of 49% of U.S. 
inpatients, revealed the readmission rates for sepsis (12.2%), myocardial infarction (1.3%), heart 
failure (6.7%), pneumonia (5.0%), and COPD (4.6%). (“Sepsis Trumps CMS’s Four Medical 
Conditions,” 2017). The estimated mean cost for a sepsis readmission was $10,070 per patient, 
also surpassing the readmission rates for the four previously mentioned diagnoses (Mayr et al., 
2017).  
Given the significant human and financial consequences of sepsis, it is crucial that 
healthcare providers identify and begin treatment of sepsis as soon as possible. Research has 
shown that screening for sepsis at the first sign of infection can lead to timely, goal-directed 
therapy (Miller, 2014).  A decrease in mortality in patients who are identified and treated in the 
early stages of the disease process, specifically before the patient advances to severe sepsis or 
septic shock has also been found. Early administration of antibiotics, intravenous fluids, source 
control, and hemodynamic support are key to preventing complications, such as acute respiratory 
distress syndrome, septic shock, and death (Perez, 2015). For example, in a study published in 
2015, researchers examined the time from blood culture collection to antibiotic administration in 
patients diagnosed with severe sepsis and septic shock. They found that the time to antibiotic 
administration was “an independent determinant of post-infection ICU and hospital length of 
stay” (Zhang, Micek, & Kollef, 2015, p. 2133).  
Centers for Medicare and Medicaid Services Guidelines 
The Centers for Medicare and Medicaid Services (CMS) is a branch of the Department of 
Health and Human Services, which administers programs such as Medicare, Medicaid, and the 
Children’s Health Insurance Program (CHIP). CMS sets standards of care for specific conditions 
in which organizations have to prove compliance in order to receive full reimbursement. When 
reimbursement is dependent on a facility’s compliance, these are called core measures. At this 
time, sepsis is not a core measure; however, it is expected to be in the near future making it even 
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more important for facilities to work towards compliance with standards and improvement of 
patient outcomes (“CMS Covers 100 Million People,” 2017).  
In 2016, CMS released recommendations for the treatment of sepsis with time intervals in 
which each component should be completed. CMS also provided a list of approved broad 
spectrum antibiotics which are considered appropriate to empirically treat patients who are septic 
until definitive blood culture results are available (Specifications Manual, 2016; CMS Sepsis 
Core Measure Algorithm, 2015/2016). CMS has made multiple revisions to the 
recommendations over the years, with little to no improvement in outcomes and mortality.  In 
fact, sepsis is now the number one killer of hospital patients (“Sepsis Trumps CMS’s Four 
Medical Conditions,” 2017).  
Best Practice Alerts 
The identification, treatment, and management of sepsis in recent years has moved 
towards a protocol or “bundle” approach. Members of the Surviving Sepsis Campaign performed 
extensive research and developed a bundle for the early treatment and management of sepsis 
(Miller, 2014). However, each facility must screen and recognize septic patients early and begin 
treatment immediately. One strategy to aid in early recognition of sepsis is the use of Best 
Practice Alerts (BPAs). BPAs are programs built into the Electronic Medical Record (EMR) 
which can be programmed to notify a provider when a patient’s charted information meets 
specific criteria. In the case of sepsis, when a patient’s clinical data charted in the EMR meet the 
set criteria for sepsis, each provider is notified when the patient’s chart is opened, signaling to 
providers that the sepsis protocol may need to be initiated. Sepsis BPAs were implemented 
within the healthcare system in 2016 with the goal of early recognition and treatment initiation to 
improve outcomes for sepsis patients.  
Purpose 
The purpose of this study was to evaluate adherence to the current CMS sepsis 
recommendations and sepsis bundle being used by the healthcare system prior to and after the 
implementation of Best Practice Alerts (BPAs). Specific questions to be answered within the 
study include: 
1. Did the use of BPAs affect compliance to variables of the sepsis bundle? 
2. Were appropriate antibiotic choices made for sepsis patients? 
3. Did the use of BPAs play a role in outcomes? 
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Methods 
The study was a single-center, process evaluation through a retrospective chart review of 
the adherence to the sepsis bundle pre and post BPA implementation at one of the health system 
hospitals. The pre-implementation period (May 1, 2016 to September 7, 2016) and post-
implementation period (September 8, 2016 to April 30, 2017) were compared with an emphasis 
on timely blood culture collection, antibiotic administration, and appropriate antibiotic choice. 
The sepsis bundle was originally implemented in December 2015.  
Setting 
 The healthcare system serves the southeast United States with five hospitals, urgent care 
clinics, and numerous primary care services. The study site is an acute care facility and has 382 
licensed beds. This facility was chosen as the focus for the study due to the high volume of 
sepsis patients treated annually. 
Sample 
 The population of interest was both male and female patients discharged from the 
hospital with a diagnosis of sepsis. Inclusion criteria encompassed: patients discharged with a 
diagnosis of sepsis and patients ages 18-65. Exclusion criteria included: patients less than 18 
years of age, patients greater than 65 years of age, and patients who had cardiac or respiratory 
arrested within 30 days of admission. The patients who met inclusion criteria during the pre-
implementation and post-implementation periods were randomly selected from the Norton 
Audubon database to reach the original target sample size of 150 patients. Two patients 
originally in the pre-implementation group failed to meet inclusion criteria.  
Measures 
 Time of admission. The time of patient admission was based on whether the admission 
occurred from 0700-1859 or 1900-0659.   
Meeting of sepsis criteria. Patients were designated as meeting sepsis criteria if they met 
either full sepsis criteria or SIRS criteria within a six hour time frame (See Appendix A). 
 Blood culture collection time. The result time of the first set of blood cultures collected 
on each patient was collected from the EMR. The number of minutes from the patients’ sepsis 
start time was calculated and categorized into intervals including 0-30 min, 31-59 minutes, 60-90 
minutes and greater than 90 minutes.   
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 Antibiotic administration time. The number of minutes from the patient’s sepsis start 
time was calculated to the first antibiotic given and categorized into intervals including 0-45 
minutes, 46-119 minutes, 120-240 minutes, and greater than 240 minutes.  
Antibiotic selection. Based on the antibiotics considered appropriate by CMS for first-
line, empiric therapy for sepsis patients, the study healthcare system narrowed the selection and 
created a formulary based on microorganisms frequently associated with sepsis patients in this 
facility. The first antibiotic given was coded as either appropriate or inappropriate. (See 
Appendix B). 
 Time of first BPA firing. The exact time of the first sepsis specific BPA fired was 
extracted from the patient’s chart. The difference in time between the first sepsis BPA firing and 
the patient’s sepsis start time was calculated and categorized into intervals including 0-30 
minutes, 31-180 minutes, 181 minutes to 6 hours, 6 hours and 1 minute to 18 hours, 18 hours and 
1 minute to 24 hours, 24 hours and 1 minute to 72 hours, and greater than 72 hours.  
 Mortality. If the patient died during the hospital stay or within 30 days of discharge, the 
patient was coded as expired.  
Data Collection 
 Prior to the start of data collection, a letter of support was granted from the healthcare 
system office of research and approval was obtained from the University of Kentucky 
Institutional Board (IRB). The study was a retrospective chart review in which charts were 
obtained from an electronic database of discharged patients. Charts were selected randomly 
based on the specified time frames and the ICD code for sepsis. Patient charts were accessed 
using medical record numbers and data were extracted based on the variables included in the 
sepsis bundle along with demographic data, including age, sex, race, and time of admission.   
Data Analysis 
Analysis of demographic data was conducted by using descriptive statistics, including 
frequency distributions, or means and standard deviations as appropriate. Independent Sample t-
tests were used to compare continuous variables between the two groups (pre-implementation of 
BPAs vs. post-implementation) while ordinal and non-normally distributed variables were 
analyzed using the Mann-Whitney U-test. To compare categorical variables between the two 
groups, the chi-squared test was used. All data analysis was conducted using SPSS version 24 
with an alpha level of .05 used for statistical significance.  
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Results 
Sample Characteristics 
The final sample consisted of 73 patients prior to BPA use and 75 patients after the initiation 
of BPAs. The mean age of both groups was 50 years of age (SD=11.7; see Table 1) with 54% of 
the total sample being male. The majority of the sample was white (82%) or African American 
(16%) and had been admitted during dayshift hours (62%). There were no differences in 
demographic characteristics between the two groups (See Table 1).  
The post-implementation group demonstrated a significant difference in whether patients met 
sepsis criteria (p=.001), with 89% meeting criteria versus 67% in the pre-implementation group. 
This group also had a higher incidence of timely antibiotic administration (p=.008), with 38% 
receiving antibiotics in 45 minutes or less of meeting sepsis criteria versus 21% of the patients in 
the pre-implementation group. Timeliness of blood culture collection was also significantly 
different, with the post-implementation group having blood cultures collected in 30 minutes or 
less in 61% of patients, versus 41% in the pre-implementation group (p=.03). The time of BPA 
firing were inconsistent with the time in which patient’s met sepsis criteria. BPAs only fired 
within 3 hours of meeting sepsis criteria in 39% of patients and in 32.2% of patients, the BPA 
fired 24 hours or more after meeting criteria. A sepsis BPA never fired in 14 of the 73 patients 
studied. There was no significant difference between groups for appropriate antibiotic selection, 
mortality, or length of stay (Table 2).  
Discussion 
Though there was no difference in patient outcomes between the two groups, there was a 
significant improvement in timeliness of blood culture collection and antibiotic administration in 
the post-implementation group. The rate of appropriate antibiotic choice increased after the 
implementation of BPAs; however, this did not change the mortality rate in the post-
implementation population. The timing of BPAs was not consistent and many times, the system 
did not fire an alert to the provider in a timely manner. Treatment was frequently initiated by a 
provider’s judgment based on clinical data and a thorough physical assessment rather than a 
BPA. Because no significant differences were found in outcomes, the differences that were 
found were likely due to frequent reeducation of providers around the sepsis bundle within the 
facility and continuous audits by an APRN who presents adherence data at monthly meetings.  
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Similar findings resulted from a single-center, before-and-after study assessing the efficacy 
of BPA use in septic patients presenting to the ED (Narayanan, Gross, Pintens, Fee, & 
MacDougall, 2016). The study included 111 patients prior to BPA implementation and 103 
patients post implementation. A higher proportion of patients in the post implementation group 
received antibiotics in less than 60 minutes. The same group also had a significant decreased 
length of stay. However, as in our study, there was no significant change in mortality between 
the two groups (Narayanan et al., 2016).   
Every sepsis patient is unique with respect to presentation, source of infection, and rate of 
progression. Care must be individualized and providers must pay attention to detail in order to 
detect and treat developing sepsis in a timely manner. These factors also play an important role 
in the choice of antibiotics. Some patients may have a clear and obvious source of infection at 
presentation; however, the ideal antibiotic may not be included in the list of recommended 
empiric antibiotics. This may lead a provider to prescribe an empiric antibiotic first, in order to 
follow hospital and CMS protocols, instead of prescribing what is appropriate for the patient. 
This delays effective treatment.  
Identifying and controlling the source of sepsis, though a difficult task, is one of the few 
ways shown to improve patient outcomes and decrease mortality. Initial investigation into the 
source of the infection should not stop after blood cultures are drawn. A thorough physical 
assessment can lead to multiple differential diagnoses which should be followed by associated 
diagnostic tests. For example, a patient with severe abdominal pain may need a CT of the 
abdomen and pelvis, which could lead to the finding of an abscess requiring emergent surgical 
intervention. Delaying these tests and treatments may lead to septic shock and death. Even with 
appropriate and timely antibiotics and fluid resuscitation, patients with certain causes of sepsis 
will not improve without immediate source control (“Sepsis: Early Recognition, Assessment, and 
Early Management,” 2016). 
Limitations 
Specific limitations of this study were identified. First, the study sample is small, making it 
difficult to show significant statistical differences between groups. The study data was also 
obtained from a single facility, making the results difficult to generalize. Also, due to the 
majority of the study population being Caucasian, the results may not be generalizable to 
minority populations. Because the data was collected through retrospective chart reviews, there 
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was no way to validate the accuracy of the information. Data may have been entered incorrectly 
into the EMR, which would alter the study findings. During a patient admission and hospital 
stay, numerous providers and staff are charting information in the EMR, which leaves significant 
room for error.  
The role in which comorbidities may have played in length of stay and outcomes was not 
accounted for in the study. Long-term morbidities which resulted from sepsis were not assessed. 
There have also been changes to CMS sepsis guidelines and recommendations since the 
completion of this study, with additional modifications expected as soon as January 1, 2018. 
Norton Healthcare also discontinued the use of BPAs after data collection was completed and 
began the use of a new strategy to screen patients for sepsis. BPAs were found to be dismissed 
frequently, due to providers using his or her own clinical judgment and assessment of data before 
deciding to initiate the sepsis order set. Also, when a BPA signals to a provider that sepsis 
criteria has been met, the provider is unable to view the patient’s chart prior to selecting an 
option from the BPA. Hypothetically, providers bypass the BPA and if the patient was found to 
be septic, the sepsis order set may not be searched for and initiated. After assessing the 
effectiveness of BPAs, the system made the decision to discontinue the use and implement a new 
sepsis screening tool which requires nursing staff to assess vital signs, labs, and physical 
assessment findings while incorporating clinical judgment as to whether or not a patient appears 
to be septic. Patients are screened at the same time intervals as physical assessments are 
conducted.  
Recommendations for Future Studies 
Future study recommendations include studying a larger sample size in order to show more 
significant differences between groups. A multi-center study would also increase generalization. 
A study which took into consideration comorbidity burden in regard to outcomes could be 
beneficial, along with studying patient outcomes based on the clinical cause of sepsis. Due to the 
importance of timely fluid administration, a study assessing the timeliness of this variable and 
outcomes would be beneficial. A study focused on readmission rates and reasons for 
readmissions may help guide treatment for sepsis patients in the future. The time between when a 
patient presents to the Emergency Department (ED) and when he or she is seen by a provider can 
lead to significant delays in treatment. Patients are also frequently admitted to 23-hour 
observation units before a diagnosis is made and aggressive treatment is started. Initiation of 
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fluid and antibiotic administration falls outside of the recommended time frames and can lead to 
poor outcomes. Research into the occurrence of these delays and potential solutions could bring 
about changes to how patients are triaged and treated when presenting to the ED with sepsis 
related symptoms. Successful treatment of sepsis is time dependent. Valuable time is often lost 
due to a delayed diagnosis of sepsis, impacting effectiveness of treatment, prognosis, and long-
term outcomes. Specifically within the Norton Healthcare system, a study assessing the 
effectiveness of the new nurse screening tool and comparing it to other facilities’ strategies could 
lead to improvements to the screening tool or another change in practice in order to improve 
patient outcomes in the setting of sepsis.  
Providers around the world have used alternative treatments for septic patients which have 
resulted in positive outcomes. Unfortunately, these treatment modalities and findings are rarely 
shared in a way that could benefit the entire population because the treatments do not follow the 
current protocols and are not evidence based. Often these providers fear coming forward and 
presenting their treatment choices and outcomes to colleagues for these very reasons. Healthcare 
providers need to be more tolerant of alternative treatment options and support further research 
and trials in order to find more effective treatments for this population. A study coordinating 
monthly round table discussions between providers around the nation about alternative 
treatments that have been effective within his or her practice could lead to new protocols and 
treatment recommendations. While individual providers may have found treatment methods that 
are successful, overall the statistics are not improving. 
Conclusion 
The purpose of this study was to assess adherence to the sepsis bundle before and after the 
implementation of BPAs. Though after the implementation of BPAs the timeliness of antibiotic 
administration and blood culture collection improved, there was no significant improvement in 
appropriate antibiotic choice, length of stay, or mortality. BPAs were also found to be 
inconsistent, frequently firing days after the patient met sepsis criteria. In some cases, a BPA did 
not fire at all. However, these findings have led to further questions and study recommendations 
which could lead to future research into the effectiveness of current treatment protocols and 
alternative treatment modalities.  
After decades of research and countless modifications to treatment protocols, sepsis remains 
a leading cause of mortality in the United States with a rate as high as 50% and has a 
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readmission rate which surpasses that of heart failure, myocardial infarction, pneumonia, and 
COPD (Rusconi et al., 2015; “Sepsis Trumps CMS’s Four Medical Conditions,” 2017). In the 
future, healthcare providers need to be more tolerant of alternative treatment options in order to 
find effective strategies to improve outcomes for sepsis patients. Multidisciplinary discussions of 
successes and failures could finally lead to decreased morbidity and mortality of this relentless 
diagnosis.  
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Table 1.  Patient Characteristics of the Study Sample 
 Total sample 
(n= 148) 
 
Mean (SD) or n (%) 
Pre-implementation 
(n=73) 
 
Mean (SD) or n (%) 
Post-
implementation 
(n=75) 
 
Mean (SD) or n (%) 
p 
Age 
 
50.4(11.7) 50.7 (10.7) 50.2 (12.7) .29 
Sex 
   Male 
   Female 
 
 
80(54.1%) 
68(45.9%) 
 
38 (52.1%) 
35(47.9%) 
 
42(56.0%) 
33(44.0%) 
.63 
Race 
   White 
   African American 
   Hispanic/Latino 
   Asian 
   Other    
 
 
121(81.8%) 
25(16.2%) 
1(0.7%) 
0(0.0%) 
2(1.4%) 
 
 
58(79.5%) 
13(17.8%) 
0(0.0%) 
0(0.0%) 
2(2.7%) 
 
63(84.0%) 
11(14.7%) 
1(1.3%) 
0(0.0%) 
0(0.0%) 
.34 
Time of admission 
   Day 0700-1859 
   Night 1900-0659 
 
91(61.5%) 
57(38.5%) 
 
46(63.0%) 
27(37.0%) 
 
45(60.0%) 
30(40.0%) 
.71 
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Table 2. Comparison of Pre and Post BPA Implementation Groups 
  
Pre-implementation 
(n=73) 
 
Mean (SD, n (%) 
or Median (range) 
 
Post-implementation 
(n=75) 
 
Mean (SD, n (%) 
or Median (range) 
 
p 
 
Sepsis Criteria Met 
    Yes 
    No 
 
 
Time of Blood Culture 
Collection 
   1-30 min 
   31-59 min 
   60-90 min 
   >90 min 
 
 
 
49(67.1%) 
24(32.9%) 
 
 
n=68 
 
28(41.2%) 
8(11.8%) 
11(16.2%) 
21(30.9%) 
 
 
67(89.3%) 
8(10.7%) 
 
 
n=75 
 
46(61.3%) 
4(5.3%) 
10(13.3%) 
15(20.0%) 
 
 
 
.001 
 
 
 
 
.03 
Time of ABX 
administration 
   1-45 min 
   46-119 min 
   120-240 min 
   >240 min 
n=70 
 
15(21.4%) 
14(20.0%) 
14(20.0%) 
27(38.6%) 
 
n=73 
 
28(38.4%) 
17(23.3%) 
12(16.4%) 
16(21.9%) 
 
.008 
Antibiotic selection 
  Appropriate 
  Inappropriate 
     
n=70 
56(80.0%) 
14(20.0%) 
n=73 
58(79.5%) 
15(20.5%) 
.94 
Time of BPA Firing 
    <30 min 
    31-180 min 
    181min- 6 hrs 
    6hrs1min-18 hrs 
    18hrs1min-24hrs 
    24hrs1min-72 hrs 
    >72 hrs 
 
N/A* n=59 
15(25.4%) 
8(13.6%) 
10(16.9%) 
7(11.9%) 
0(0.0%) 
6(10.2%) 
13(22.0%) 
N/A* 
Mortality 
   Expired 
   Alive 
 
 
6(8.2%) 
67(91.8%) 
 
10(13.3%) 
65(86.7%) 
 
.32 
Length of stay 6 (0-45) 7 (1-30) .97 
 
*The pre-implementation group data was pulled prior to the use of BPAs, therefore there are no 
BPA firing times for this group. 
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Appendix A. Sepsis Criteria 
 
Vital Sign Abnormalities (must have two)  Temperature >38.3 C or <36.0 C 
 
 Heart rate >90 beats/min 
 
 Respiratory rate >20 per/min 
 
 White blood cell count >12,000 or 
<4,000 or >10% bands 
 
Presence of Suspected Infection Any indication of suspected infection noted 
by MD, APRN, PA, Pharmacist, or RN 
 
Organ Dysfunction (must have one)  Systolic blood pressure (SBP) <90, or 
mean arterial pressure <65, or a SBP 
decrease of more than 40 mmHg from 
the last previously recorded SBP 
considered normal for that specific 
patient 
 
 Creatinine >2.0, or urine output <0.5 
mL/kg/hour for 2 hours 
 
 Bilirubin >2 mg/dL (34.2 mmol/L) 
 
 Platelet count <100,000 
 
 INR >1.5 or a PTT > 60 sec 
 
 Lactate > 2 mmol/L (18.0 mg/dL) 
 
 Respiratory failure (must be 
documented by an LIP or RN) 
  
 
 
 
 
 
 
 
(CMS Sepsis Core Measure Algorithm, 2015) 
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Appendix B. Broad Spectrum Antibiotics 
 
cefepime (Maxipime) 
levofloxacin (Levaquin) 
piperacillin-tazobactam (Zosyn) 
aztreonam (Azactam) + Vancomycin 
ceftriaxone (Rocephin) 
meropenem (Merrem) 
metronidazole (Flagyl) only counts if the patient has Clostridium difficile infection 
Vancomycin only counts if the patient has Clostridium difficile infection 
 
 
 
 
 
 
 
 
 
 
 
 
(Healthcare Organization’s Formulary of Sepsis Antibiotics) 
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